Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ...

Stallergenes Greer, a global leader in allergy therapeutics, will present insightful scientific developments at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, Glasgow ...

enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for ...

Triple-negative breast cancer (TNBC) - closeup view 3d illustration] Nemes Laszlo/iStock via Gilead Sciences (NASDAQ:GILD [ announced Saturday that its antibody-drug conjugate Trodelvy, in ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the ...

Ernexa Therapeutics announced that data on its novel immunotherapy platform using induced mesenchymal stem cells (iMSCs) will be presented at the ASCO Annual Meeting 2025 on June 2 in Chicago.

Get Instant Summarized Text (Gist) Analysis of single-cell RNA and TCR sequencing from cancer patients treated with immunotherapy identified a distinct genetic signature in T cell clones of responders ...

"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," researchers said Kimberlee Speakman is a digital writer at PEOPLE. She has been ...

I couldn't believe it worked that quick, to be honest," Knolmayer told CBS News. He's part of an immunotherapy study that could fundamentally change the way certain cancers are treated.

A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results. By Gina Kolata When a person ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...